Company Quick10K Filing
OLB Group
10-Q 2020-09-30 Filed 2020-11-12
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-05-15
10-K 2019-12-31 Filed 2020-04-29
10-Q 2019-09-30 Filed 2019-11-15
10-Q 2019-06-30 Filed 2019-08-14
S-1 2019-06-26 Public Filing
10-Q 2019-03-31 Filed 2019-05-16
10-K 2018-12-31 Filed 2019-04-18
10-Q 2018-09-30 Filed 2018-11-19
10-Q 2018-06-30 Filed 2018-08-22
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-13
10-Q 2017-09-30 Filed 2017-11-16
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-04-12
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-04-01
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-05
10-Q 2015-03-31 Filed 2015-05-14
10-K 2014-12-31 Filed 2015-03-23
10-Q 2014-09-30 Filed 2014-11-04
10-Q 2014-06-30 Filed 2014-08-11
10-Q 2014-03-31 Filed 2014-05-12
10-K 2013-12-31 Filed 2014-03-28
10-Q 2013-09-30 Filed 2013-11-08
10-Q 2013-03-31 Filed 2013-05-10
10-K 2012-12-31 Filed 2013-04-01
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-04-30 Filed 2013-07-19
10-Q 2012-03-31 Filed 2012-05-07
10-K 2011-12-31 Filed 2012-03-20
10-Q 2011-09-30 Filed 2011-11-03
10-Q 2011-06-30 Filed 2011-07-29
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-25
10-Q 2010-09-30 Filed 2010-11-08
10-Q 2010-06-30 Filed 2010-07-21
10-Q 2010-03-31 Filed 2010-05-10
10-K 2009-12-31 Filed 2010-03-30
8-K 2020-11-13
8-K 2020-10-23
8-K 2020-10-08
8-K 2020-09-11
8-K 2020-08-17
8-K 2020-08-06
8-K 2020-06-24
8-K 2020-05-22
8-K 2020-03-20
8-K 2019-11-12
8-K 2019-03-01
8-K 2019-01-25
8-K 2018-10-09
8-K 2018-07-30
8-K 2018-05-09
8-K 2018-04-09

OLB Group Financials

OLBG Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-04-302012-09-302012-12-312013-03-312013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-09-302018-12-312019-03-312019-06-302019-09-30
Cash18110824913396200013502112010112435525
Accounts Receivable25406477509605
Inventory
PP&E00000066575043
Assets43434727921013971468839117555681057667562011,99911,77111,62511,509
Accounts Payable18162218192735414276468460543571
Long-Term Debt9,5009,5009,5009,500
Liabilities237281289319211535851412721282052803692211620329218941682603304245246389321613,72113,83414,09414,314
Stockholders' Equity19766-10-109-197-438-72-134-264-120-166-269-362-17-111-197-285-10-84-163-253-323-417-517-633-88-196-1,722-2,063-2,469-2,805
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-04-302012-09-302012-12-312013-03-312013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue4939492928313222242976133117181215212619830151810102,5912,5822,477
Cost of Revenue171515151012910512986776746555555
Gross Profit332434141819231219176752510115917201432510135
R&D
SG&A372473313589493040324135445336212418252421202736432320273488294
Tax000000000000000000000000000
Net Income-208-131-203-148-88-217-273-88-92-284-46-103-93-118-94-86-88-74-74-79-90-71-94-100-116-89-108-407-473-402
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-04-302012-09-302012-12-312013-03-312013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-181-51-43-41-33-31-25-19-34-29-55-50-50-52-48-6-32-73-54-15-38-20-31-114-75-113
Cash Investing0000000000000000000000000000
Cash Financing1-15050252525252530255350505350828755316380031458883